The Valley Desk

NCT02745119 · Interventional trial

Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)

Overall registry status Terminated

Phase 3

Conditions Geographic Atrophy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov